Agnelli et al. reclassified 11% of PTCL-NOS cases as ALCL using a 3-gene model (TNFRSF8, BATF3, and TMOD1) with 97% accuracy (61). This evidence concerns the gene TNFRSF8 and mature T-cell and NK-cell non-Hodgkin lymphoma.